Navigation Links
Oramed Pharmaceuticals Announces Filing of Two Registration Statements
Date:1/11/2010

JERUSALEM, Israel, January 11 /PRNewswire-FirstCall/ -- Oramed Pharmaceuticals Inc. (OTCBB: ORMP.OB), a developer of alternative drug delivery systems, today announced that it has filed two registration statements on Form S-1 with the Securities and Exchange Commission.

One registration statement relates to a proposed public offering by Oramed of 24 million shares of common stock and warrants to purchase 12 million shares of common stock, as well as warrants to purchase up to approximately 2.5 million shares of common stock issuable to the placement agent of the offering.

This offering shall be made only by means of a prospectus. Copies of the preliminary prospectus, when available, may be obtained from Oramed. The registration statement may be accessed through the SEC's website at http://www.sec.gov.

Oramed expects to use the net proceeds from the offering to fund its planned research and development activities, as well as some other general and administrative costs.

The second filing is a shelf registration statement relating to a resale offering by certain Oramed stockholders of approximately 8.5 million shares of common stock and approximately 4.8 million shares of common stock issuable upon the exercise of warrants held by stockholders of Oramed who purchased such securities in private placement transactions.

This press release is made in accordance with Rule 135 under the Securities Act. Registration statements relating to these securities have been filed with the Securities and Exchange Commission but have not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time the applicable re
'/>"/>

SOURCE Oramed Pharmaceuticals Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Oramed Pharmaceuticals was Chosen to Present Results of a GLP-1 Analog Oral Administration Study at the Diabetes Technology Societys Ninth Annual Meeting (November 5-7, 2009; San Francisco, CA)
2. Orameds Chief Scientific Officer, Miriam Kidron, Ph.D., Chosen to Lecture at the 2009 British Pharmaceutical Conference in Manchester, England
3. Oramed Pharmaceuticals to Present at the 8th National Life Science & Technology Week ILSI -BIOMED Conference, Israel 2009
4. Oramed Pharmaceuticals Announces Launch of Phase 2B Clinical Trials in South Africa of its Oral Insulin Capsule
5. Oramed Pharmaceuticals to Present Oral Insulin Phase 2A Trial Results at the Upcoming Annual Meeting of the ADA (June 5-9, New Orleans, LA)
6. Oramed Pharmaceuticals Completes Proof of Concept Study of Insulin Suppository
7. Oramed Pharmaceuticals Chosen to Present Results of GLP-1 Analog Enteral Administration Study at the Diabetes Technology Societys Eighth Annual Meeting (November 13-15, 2008; Bethesda, Maryland)
8. Oramed Pharmaceuticals Launches Phase 1A Trials of its Insulin Suppository
9. /K I L L K I L L K I L L -- Oramed Pharmaceuticals Inc./
10. Oramed Pharmaceuticals Commences Phase 2A Trials of its Oral Insulin Capsule on Type 1 Diabetics
11. Oramed Pharmaceuticals Launches GLP1-Analog Program, Based on its Proprietary Drug Delivery Platform
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/25/2014)... , Oct. 24, 2014  According to a survey ... MOSAIQ® Oncology Information System earned the number one ... KLAS, "Oncology 2014: Integration is Key" report. The survey ... has improved their MOSAIQ interfaces to take a commanding ... 100, 93 percent of customers said they would buy ...
(Date:10/25/2014)... DUBLIN , Oct. 24, 2014 ... "Dental Equipment Market Current Trends, Opportunities - Global ... In this report, the global dental equipment ... geography. The dental systems and equipment market is expected ... equipment market during the forecast period (2014 to 2019). ...
(Date:10/25/2014)... , Oct. 24, 2014 Advanced Photonix ® ... September 26, 2014) financial results on Monday, November 10, 2014. ... after the close of the market and the Company will ... at 4:30 p.m. EDT on the same day. ... (CEO and Director), Rob Risser (COO and Director), ...
Breaking Medicine Technology:Elekta's MOSAIQ oncology information system ranks number one in KLAS Oncology 2014 report 2Elekta's MOSAIQ oncology information system ranks number one in KLAS Oncology 2014 report 3Dental Equipment Market Current Trends, Opportunities - Global Forecast to 2019 2Dental Equipment Market Current Trends, Opportunities - Global Forecast to 2019 3Advanced Photonix to Webcast Fiscal 2015 Second Quarter Earnings 2
... YORK, Sept. 23 Reportlinker.com announces that a ... catalogue: Genzyme Corporation: PharmaVitae Profile ... Introduction This analysis examines the historical ... pharmaceutical sector. The profile encompasses global company strategy, ...
... Calif., Sept. 23 Preclinical data of a ... blood pressure) was presented Tuesday, September 21st, at ... Washington, DC, by Christopher D. Owens, MD, MSc, ... Endovascular Surgery, University of California, San Francisco. The ...
Cached Medicine Technology:Reportlinker Adds Genzyme Corporation: PharmaVitae Profile 2Reportlinker Adds Genzyme Corporation: PharmaVitae Profile 3Reportlinker Adds Genzyme Corporation: PharmaVitae Profile 4Reportlinker Adds Genzyme Corporation: PharmaVitae Profile 5Reportlinker Adds Genzyme Corporation: PharmaVitae Profile 6Reportlinker Adds Genzyme Corporation: PharmaVitae Profile 7Promising New Therapy for Drug-Resistant Hypertension Presented at Interventional Cardiology Meeting in Washington, D.C. 2
(Date:10/25/2014)... (PRWEB) October 25, 2014 More than ... President’s Circle Reception on Monday at the home of ... and hear from guest speaker Dr. Winifred Lender on ... , Dr. Lender, a Santa Barbara psychologist, author and ... and benefits of living in the digital age. Our ...
(Date:10/25/2014)... Background: , In 1998 Bob Savage founded the ... in the field of establishing recovery community organizations. Bob ... when he retired, he set out to answer a couple ... , 1. Where are the people in recovery ... 2. Can the recovery community be organized to advocate for ...
(Date:10/25/2014)... (PRWEB) October 25, 2014 TASC ... medical and other benefits account management services, announces ... help employers save on taxes, reduce administrative workload, ... provide tax savings and the efficient handling of ... the Suite that best meets their goals and ...
(Date:10/25/2014)... Minnesota (PRWEB) October 25, 2014 ... testing firm which verifies IT-accessibility for disabled users ... Access Approved® logo to Mackin Educational Resources ... digital resource management system and to the Minnesota ... the "Own Best Medicine" website. ...
(Date:10/25/2014)... Dallas, TX (PRWEB) October 25, 2014 ... and Chinese Molecular Diagnostics Industry, 2009-2019 is ... Global and Chinese Molecular Diagnostics industry. The ... Molecular Diagnostics including its classification, application and ... and China’s top manufacturers of Molecular Diagnostics ...
Breaking Medicine News(10 mins):Health News:Finding Balance between the Real & Digital World Topic of Family Service Agency Reception 2Health News:Finding Balance between the Real & Digital World Topic of Family Service Agency Reception 3Health News:Finding Balance between the Real & Digital World Topic of Family Service Agency Reception 4Health News:CCAR Accepting Nominations for the Bob Savage Recovery Advocate of the Year Award 2Health News:TASC’s New Suites Offer Tax Savings and Protection 2Health News:IT-Accessibility Award Granted to Education and Health Care for Section 508/WCAG 2Health News:IT-Accessibility Award Granted to Education and Health Care for Section 508/WCAG 3Health News:Global and China Molecular Diagnostics Industry Analysis to 2019 is Now Available at RnRMarketResearch.com 2Health News:Global and China Molecular Diagnostics Industry Analysis to 2019 is Now Available at RnRMarketResearch.com 3Health News:Global and China Molecular Diagnostics Industry Analysis to 2019 is Now Available at RnRMarketResearch.com 4
... University of Michigan Medical School and MedImmune, the global ... to work together on a broad range of projects. ... one of the nation,s top medical research institutions together ... of biologic therapies. UMMS and MedImmune scientists ...
... and subsequent left-ventricular function are significantly different based on the ... of its kind study in humans, published online Nov. 17 ... to the heart occurs when individuals have a heart attack ... size in rodents following ischemia and reperfusion exhibited a circadian ...
... SUNDAY, Nov. 20 (HealthDay News) -- Holiday foods and ... Americans with gastroesophageal reflux disease (GERD), but there are ... experts advise. GERD occurs when a faulty valve ... flow back into the esophagus. Symptoms of GERD include ...
... drug believed to prevent dysfunction of mitochondria, the ... appears to slow symptom progression in the neurodegenerative ... a phase 2 trial of dexpramipexole are receiving advance ... of the study were presented at the 2009 International ...
... SATURDAY, Nov. 19 (HealthDay News) -- Eating certain foods ... after you,ve used an at-home whitening kit or had ... who have had good results with either dentist-directed or ... keep the teeth white after bleaching," Dr. Raymond Garrison, ...
... By Randy Dotinga HealthDay Reporter , FRIDAY, Nov. ... more likely to lie to strangers when they,re communicating via ... face-to-face. "It,s not news that we lie. What,s new ... Mattitiyahu Zimbler, a graduate student and senior researcher at the ...
Cached Medicine News:Health News:U-M Medical School and MedImmune join forces to accelerate search for new therapies 2Health News:Severity of heart attack is dependent on the time of day 2Health News:Holiday Foods May Trigger GERD Symptoms 2Health News:Novel ALS drug slows symptom progression, reduces mortality in phase 2 trial 2Health News:Novel ALS drug slows symptom progression, reduces mortality in phase 2 trial 3Health News:Watch What You Eat After Teeth-Whitening, Expert Says 2Health News:People May Lie More Often in Emails, Instant Messages 2
Double-ended. Sharp and blunt 6.5 mm tips. Designated most popular model or size....
Octagonal handle. 3 mm wide....
Desmarres Retractor Size 4...
2.0 mm cup , straight shaft, Flat handle, length 125.0 mm....
Medicine Products: